VIROSTOP – No. 1 in Antiviral Protection
Interest in products with MDR certification is growing, and VIROSTOP leads the way. Swiss company Herb-Pharma AG delivers a proven antiviral mechanism based on plant extracts rich in polyphenols and is preparing a new generation of products – VIROSTOP Forte.
Growing Interest in Products with MDR Certification
VIROSTOP, the flagship brand of Swiss company Herb-Pharma
AG (Zurich), has seen a significant increase in interest from business
partners across Europe in recent months.
This trend confirms the growing demand for medical devices
with demonstrated antiviral efficacy and, crucially, valid MDR
certification, which most products in this category lack. The increased
market interest thus reflects a shift from ordinary over-the-counter products
to solutions that meet strict European standards of safety, quality, and
clinical validation.
What is VIROSTOP
VIROSTOP contains a patented blend of extracts
from five carefully selected plants. The Swiss scientific team combined them
after extensive research so that their effects mutually support each other and
create a robust, continuous film to protect the mucous membranes of the upper
respiratory tract.
The VIROSTOP formulation supports the
body's natural resistance against influenza, colds, and runny nose. The extract
with high content of plant polyphenols prevents viruses and bacteria from
penetrating the body and causing infection. It acts locally on the mucosa,
without systemic effects. No adverse effects have been recorded with its use to
date.
Mechanism of Action
The mucous membrane of the respiratory tract serves as a
natural barrier that prevents viruses and bacteria from entering the body's
cells. The cells form a thin layer of mucopolysaccharides on their surface,
which also contains many defensive substances and immune cells. However, if
there are many attacking viruses and bacteria at once, its capabilities become
exhausted and pathogens can succeed in causing infection.
The solution in VIROSTOP products
contributes to natural defense capacity by depositing a mixture of active
substances from plants on the surface of the upper respiratory tract mucosa.
These help neutralize viruses, block their binding sites, and thus prevent them
from penetrating cells that they could otherwise infect.
In an already ongoing infection, these substances can
prevent multiplied viruses from attacking other surrounding cells. They
contribute to slowing the spread of infection and thus help restore the
function of the respiratory tract mucosa.
For this very reason, it is best to start using VIROSTOP at
the first signs of illness, as well as preventively when moving in environments
with increased risk of infection.
Oral Spray, Nasal Spray, and Pastilles
The VIROSTOP brand range includes oral
spray, nasal spray, and pastilles, which form a coherent line of antiviral
products. Since the entry point of infection can be either nasal or oral
mucosa, each form specifically acts on a different site and complements one
another in mutual effect. Each application form creates a protective film on
the mucosa of the nasal or oral cavity, thereby preventing virus penetration
into the body and limiting their multiplication. They prevent the development
of infection, especially influenza, colds, and runny nose, alleviate symptoms
of acute upper respiratory tract infections – such as sore throat, cough,
sneezing, nasal discharge, or stuffy nose – and shorten the duration of
symptoms.
VIROSTOP FORTE – The Next Step in Development
Based on long-term research, Herb-Pharma AG is
preparing the launch of a new generation of VIROSTOP Forte products,
which take the brand's efficacy even further. The new oral spray and pastilles
will combine patented plant extracts with biotechnological peptides and
glycerol, thereby creating an even longer-lasting and more resistant protective
film. The peptides enhance the antiviral mechanism, and glycerol prolongs the
action of active substances on the mucosa, while simultaneously increasing
their solubility and comfort during use.
